BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 33962487)

  • 41. The Monocyte Monolayer Assay: Past, Present and Future.
    Tong TN; Cen S; Branch DR
    Transfus Med Rev; 2019 Jan; 33(1):24-28. PubMed ID: 30139679
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acute hemolytic transfusion reaction associated with anti-Mt
    Claes V; Peyrard T; Deleers M; El Kenz H
    Transfusion; 2019 Nov; 59(11):3314-3318. PubMed ID: 31503331
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute hemolysis of transfused A2 red cells by an auto-HI antibody.
    Darabi K; Makar RS
    Transfusion; 2008 May; 48(5):964-8. PubMed ID: 18454737
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Successful use of eculizumab for treatment of an acute hemolytic reaction after ABO-incompatible red blood cell transfusion.
    Weinstock C; Möhle R; Dorn C; Weisel K; Höchsmann B; Schrezenmeier H; Kanz L
    Transfusion; 2015 Mar; 55(3):605-10. PubMed ID: 25251967
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An acute hemolytic transfusion reaction caused by dog erythrocyte antigen 1.1 incompatibility in a previously sensitized dog.
    Giger U; Gelens CJ; Callan MB; Oakley DA
    J Am Vet Med Assoc; 1995 May; 206(9):1358-62. PubMed ID: 7775248
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-Jk
    Kay B; Poisson JL; Tuma CW; Shulman IA
    Transfusion; 2016 Dec; 56(12):2973-2979. PubMed ID: 27596036
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of A plasma for incompatible patients.
    Olsen G; Passwater M; Huggins M; Mukhtar F; Pelletier P
    Transfusion; 2021 Feb; 61(2):375-378. PubMed ID: 33219552
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An acute hemolytic transfusion reaction caused by an anti-P1 that reacted at 37 degrees C.
    Arndt PA; Garratty G; Marfoe RA; Zeger GD
    Transfusion; 1998 Apr; 38(4):373-7. PubMed ID: 9595020
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-Dob implicated as the cause of a delayed hemolytic transfusion reaction.
    Moheng MC; McCarthy P; Pierce SR
    Transfusion; 1985; 25(1):44-6. PubMed ID: 3969700
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Challenges in preventing and treating hemolytic complications associated with red blood cell transfusion.
    Chonat S; Arthur CM; Zerra PE; Maier CL; Jajosky RP; Yee MEM; Miller MJ; Josephson CD; Roback JD; Fasano R; Stowell SR
    Transfus Clin Biol; 2019 May; 26(2):130-134. PubMed ID: 30979566
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transfusions of least-incompatible blood with intravenous immunoglobulin plus steroids cover in two patients with rare antibody.
    Win N; Needs M; Thornton N; Webster R; Chang C
    Transfusion; 2018 Jul; 58(7):1626-1630. PubMed ID: 29732576
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HEMOLYTIC TRANSFUSION REACTIONS.
    STUCKEY MA; OSOBA D; THOMAS JW
    Can Med Assoc J; 1964 Mar; 90(12):739-41. PubMed ID: 14130497
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute Hemolytic Transfusion Reaction Caused by a Red Cell Antibody That Was Missed by Pretransfusion Testing Using Tube Method.
    Shmookler A; Hamad D; Scrape S; Chen J
    Lab Med; 2017 Aug; 48(3):258-261. PubMed ID: 28934518
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Red cell alloimmunization in a transfused patient population: a study from a tertiary care hospital in north India.
    Thakral B; Saluja K; Sharma RR; Marwaha N
    Hematology; 2008 Oct; 13(5):313-8. PubMed ID: 18854096
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Release of mediators of systemic inflammatory response syndrome in the course of a severe delayed hemolytic transfusion reaction caused by anti-D.
    von Zabern I; Ehlers M; Grunwald U; Mauermann K; Greinacher A
    Transfusion; 1998 May; 38(5):459-68. PubMed ID: 9633559
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug-induced hemolysis: cefotetan-dependent hemolytic anemia mimicking an acute intravascular immune transfusion reaction.
    Stroncek D; Procter JL; Johnson J
    Am J Hematol; 2000 May; 64(1):67-70. PubMed ID: 10815791
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hemolytic transfusion reactions in a dog with an alloantibody to a common antigen.
    Callan MB; Jones LT; Giger U
    J Vet Intern Med; 1995; 9(4):277-9. PubMed ID: 8523326
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The first reported case of anti-Dob causing an acute hemolytic transfusion reaction.
    Halverson G; Shanahan E; Santiago I; Mabile R; Thurrell T; Strupp AM; Wolf CF; Spruell P; Moulds MK
    Vox Sang; 1994; 66(3):206-9. PubMed ID: 8036791
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk of hemolytic transfusion reactions following emergency-release RBC transfusion.
    Goodell PP; Uhl L; Mohammed M; Powers AA
    Am J Clin Pathol; 2010 Aug; 134(2):202-6. PubMed ID: 20660321
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies.
    Josephson CD; Castillejo MI; Grima K; Hillyer CD
    Transfus Apher Sci; 2010 Feb; 42(1):83-8. PubMed ID: 20034854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.